Latest

vision loss

Featured Genetics Neuroscience Visual Neuroscience

·March 17, 2023·3 min read

CRISPR Gene-Editing Technique Reverses Vision Loss in Mice

Using a highly versatile form of CRISPR gene editing, researchers successfully restored vision in mice with retinitis pigmentosa.

Featured Neuroscience Visual Neuroscience

·February 25, 2023·4 min read

New Way to Prevent AMD, a Common Cause of Vision Loss

Study uncovered a previously unknown contributor to harmful blood vessel growth in the eye associated with AMD and other common vision loss disorders. The findings could lead to new treatments for those suffering from age-related macular degeneration and other vision loss disorders.

Featured Neuroscience Visual Neuroscience

·January 19, 2023·6 min read

A Small Molecule That Restores Visual Function After Optic Nerve Injury Identified

Researchers identified a small molecule capable of stimulating nerve regeneration and restoring vision following injury to the optic nerve.

This shows an image of the cells within an eye

Featured Genetics Neuroscience Open Neuroscience Articles Visual Neuroscience

·January 17, 2023·4 min read

Combining Multiple Maps Reveals New Genetic Risk Factors for Age-Related Macular Degeneration

Study uncovers new genetic risk factors for age-related macular degeneration, a leading cause of vision loss in adults.

Featured Neuroscience Visual Neuroscience

·January 9, 2023·5 min read

Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition AMD

Study demonstrates two different types of deposits in the retina that appear to contribute to age-related macular degeneration.

Featured Neuroscience

·December 8, 2022·4 min read

AI Technology to Help Reduce the Risk of Vision Loss and Stroke

New AI technology is able to detect changes to the retina and predict the risk of retinal vein occlusion. Researchers say the technology could also be used to detect heart attack and stroke risks.

Featured Neurology Neuroscience Visual Neuroscience

·November 17, 2022·5 min read

Age-Related Macular Degeneration Associated With Serious Forms of Cardiovascular Disease

People with subretinal drusenoid deposits (SDD), a form of age-related macular degeneration, are more likely to have underlying heart damage as a result of heart failure or heart attacks, or other forms of cardiovascular disease associated with increased stroke risk.

Featured Neuroscience Open Neuroscience Articles Visual Neuroscience

·November 2, 2022·6 min read

Poor Quality Sleep May Be Linked to Heightened Risk of Irreversible Sight Loss

Those who suffer from poor sleep quality, including daytime sleepiness, snoring, or getting too much or too little sleep, are at increased risk of developing glaucoma.

Featured Genetics Neuroscience Visual Neuroscience

·October 6, 2022·4 min read

The Adult Brain Can Recover Lost Vision

Administering a chemical compound called synthetic retinoids to the retina helped restore brain networks associated with vision and prompted the growth of two times more neurons, effectively restoring vision in adult mouse models of the genetic visual disorder LCA.

Featured Neuroscience Visual Neuroscience

·September 23, 2022·3 min read

Uncovering the Key Process That Contributes to Vision Loss and Blindness in People With Diabetes

The loss of blood flow autoregulation caused by diabetes is the result of the disruption of the TRPV2 protein. Even in the absence of diabetes, disrupted blood flow autoregulation causes damage closely resembling that seen in diabetic retinopathy.

Featured Neuroscience Visual Neuroscience

·September 7, 2022·4 min read

A Single Protein Could Unlock Age-Related Vision Loss

Determining the structure of vitronectin, a protein implicated in age-related macular degeneration and some neurodegenerative disorders, and using pressure to alter the protein shape may help in the development of new treatments for AMD.

Featured Genetics Neuroscience Visual Neuroscience

·August 25, 2022·3 min read

New Gene Therapy Shows Promise for Treating Age Related Macular Degeneration

A new study reports that a new gene therapy shows promise in treating dry age-related macular degeneration. The gene therapy, ophNdi1, directly targets mitochondrial function that is malfunctioning in AMD.